TIARA — Training in Implementation: Actionable Research Approaches

Accreditation
Continuing Medical Education
The University of Missouri - Columbia School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Missouri - Columbia School of Medicine, designates this live educational activity for a maximum of 21 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Nursing Contact Hours
University of Missouri Sinclair School of Nursing is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Participant may earn 21 contact hours.

Missouri Board of Pharmacy
The Continuing Education Committee of the Missouri Board of Pharmacy has reviewed and approved the Training in Implementation: Actionable Research Approaches (TIARA) for continuing education.

• Program Number: 2024-01-14
• Approved Contact Hours: 14 CE(s) 

Relevant Financial Relationship Disclosures 
Current ACCME (Accreditation Council for Continuing Medical Education) and Midwest Multistate Division, ANCC (American Nurses Credentialing Center’s Commission on Accreditation) rules state that participants in CE activities should be made aware of any relevant affiliation or financial interest in the previous 24 months that may affect the planning of an educational activity or a speaker’s presentation(s). Each planning committee member and speaker has been requested to complete a financial relationship reporting form for the Training in Implementation: Actionable Research Approaches (TIARA) Activity. 

• Stacy Farr is a consultant for Novartis. 
• Emily O’Brien receives research grants from Pfizer and Bristol Myers Squibb 
• Brant Oliver receives research funding from disclosed research funding EMD Serono 
• John Spertus is a consultant with Abbott, Alnylam, AstraZeneca, Bayer, Merck, Janssen, Bristo Myer Squibb, Edwards, Kineksia, 4DT Medical, Terumo, Cytokinetics, and Imbria. He receives research grants from Bristol Myer Squibb, Abbott Vascular, NCDR, and Janssen. Receives licensed intellectual property from copyrights to the Seattle Angina Questionnaire, Kansas City Cardiomyopathy Questionnaire, and Peripheral Artery Questionnaire. He is a board member of Blue Cross Blue Shield of Kansas City. 

All financial relationships have been mitigated. 

No other planning committee members or speakers have disclosed financial relationships.